Schett G - Search Results

1

Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.

Aringer M, Burkhardt H, Burmester GR, Fischer-Betz R, Fleck M, Graninger W, Hiepe F, Jacobi AM, Kötter I, Lakomek HJ, Lorenz HM, Manger B, Schett G, Schmidt RE, Schneider M, Schulze-Koops H, Smolen JS, Specker C, Stoll T, Strangfeld A, Tony HP, Villiger PM, Voll R, Witte T, Dörner T. Aringer M, et al. Among authors: schett g. Lupus. 2012 Apr;21(4):386-401. doi: 10.1177/0961203311426569. Epub 2011 Nov 9. Lupus. 2012. PMID: 22072024 Review.

2

Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation.

Schett G, Steiner G, Smolen JS. Schett G, et al. Arthritis Rheum. 1998 Aug;41(8):1446-55. doi: 10.1002/1529-0131(199808)41:8<1446::AID-ART15>3.0.CO;2-6. Arthritis Rheum. 1998. PMID: 9704644

3

Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70.

Schett G, Steiner CW, Gröger M, Winkler S, Graninger W, Smolen J, Xu Q, Steiner G. Schett G, et al. FASEB J. 1999 May;13(8):833-42. doi: 10.1096/fasebj.13.8.833. FASEB J. 1999. PMID: 10224227

4

The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.

Schett G, Rubin RL, Steiner G, Hiesberger H, Muller S, Smolen J. Schett G, et al. Arthritis Rheum. 2000 Feb;43(2):420-8. doi: 10.1002/1529-0131(200002)43:2<420::AID-ANR24>3.0.CO;2-Z. Arthritis Rheum. 2000. PMID: 10693884 Free article.

5

Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus.

Schett G, Firbas U, Füreder W, Hiesberger H, Winkler S, Wachauer D, Köller M, Kapiotis S, Smolen J. Schett G, et al. Rheumatology (Oxford). 2001 Apr;40(4):424-31. doi: 10.1093/rheumatology/40.4.424. Rheumatology (Oxford). 2001. PMID: 11312382

6

Obstruction of the pulmonary artery by granulomatous vasculitis: a clinical, morphological, and immunological analysis.

Schett G, Winkler S, Hollenstein U, Amann G, Willheim M, Prokop M, Klepetko W, Becherer A, Smolen J, Graninger W. Schett G, et al. Ann Rheum Dis. 2002 May;61(5):463-7. doi: 10.1136/ard.61.5.463. Ann Rheum Dis. 2002. PMID: 11959774 Free PMC article. Review. No abstract available.

7

Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus.

Füreder W, Firbas U, Nichol JL, Pistillo J, Winkler S, Hiesberger H, Sperr WR, Smolen J, Schett G. Füreder W, et al. Among authors: schett g. Lupus. 2002;11(4):221-6. doi: 10.1191/0961203302lu177oa. Lupus. 2002. PMID: 12043885

8

The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.

Schett G, Smole J, Zimmermann C, Hiesberger H, Hoefler E, Fournel S, Muller S, Rubin RL, Steiner G. Schett G, et al. Lupus. 2002;11(11):704-15. doi: 10.1191/0961203302lu247oa. Lupus. 2002. PMID: 12475000

9

The role of osteoprotegerin in arthritis.

Schett G, Redlich K, Smolen JS. Schett G, et al. Arthritis Res Ther. 2003;5(5):239-45. doi: 10.1186/ar990. Epub 2003 Aug 8. Arthritis Res Ther. 2003. PMID: 12932284 Free PMC article. Review.

10

TNFalpha mediates susceptibility to heat-induced apoptosis by protein phosphatase-mediated inhibition of the HSF1/hsp70 stress response.

Schett G, Steiner CW, Xu Q, Smolen JS, Steiner G. Schett G, et al. Cell Death Differ. 2003 Oct;10(10):1126-36. doi: 10.1038/sj.cdd.4401276. Cell Death Differ. 2003. PMID: 14502236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,081 results

Search Page

Filters